Approval · Notice of Compliance 4472 · 1996
ROFERON-A: Notice of Compliance 4472
Issued March 29, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4472
- Date
- March 29, 1996
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New albumin (human) free formulation
- Therapeutic class
- Biological response modifier
Products in this notice
Medicinal ingredients
- INTERFERON ALPHA-2A 3 M per ML
- INTERFERON ALPHA-2A 4.5 M per ML
- INTERFERON ALPHA-2A 6 M per ML
- INTERFERON ALPHA-2A 9 M per ML
- INTERFERON ALPHA-2A 18 M per 3ML